India, Feb. 1 -- A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate,cb1, capable of generating broad immunity ...
You still have time to protect yourself and your loved ones.